In addition, EMT-TFs have been shown to upregulate the expression of pro-inflammatory and immunosuppressive cytokines such as TGF-β and IL-10 in cancer cells, thereby triggering tumour promoting effects on the TME. This evidence concerns the gene TGFB1 and cancer.